Search results
Results from the WOW.Com Content Network
Antithrombin III deficiency (abbreviated ATIII deficiency) is a deficiency of antithrombin III. This deficiency may be inherited or acquired. [ 1 ] It is a rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism , and repetitive intrauterine fetal death (IUFD). [ 2 ]
The score of the QoL-AGHDA is used to determine the extent to which growth hormone deficiency has affected the patient’s quality of life, and what treatment can then be administered. A high score on the QoL-AGHDA indicates that the patient suffers from many symptoms and therefore has a lower quality of life.
Reagent test Alcohols: Forms Lucas test in alcohols is a test to differentiate between primary, secondary, and tertiary alcohols. Alkaloids: Forms Froehde Liebermann Mandelin Marquis Mayer's Mecke Simon's: Amines, and amino acids: Forms Folin's: Barbiturates: Class Dille–Koppanyi Zwikker: Benzodiazepines: Class Zimmermann: Phytocannabinoids ...
The aPTT-based APC resistance test involves a modified aPTT test performed in the presence and absence of activated protein C (APC). [1] [5] The ratio of these aPTT values is calculated and is called the APC sensitivity ratio (APCsr) or simply APC ratio (APCr). [1] [5] This ratio is inversely related to the degree of APC resistance. [7]
5,10-methenyltetrahydrofolate synthetase deficiency: MTHFS [2] 7p22.1 microduplication syndrome: 7p22.1 17q12 microdeletion syndrome: 17q12 [3] [4] 1:14,000-62,500 17q12 microduplication syndrome: 17q12 [5] 18p deletion syndrome: 18p D 1:50,000 21-hydroxylase deficiency: 6p21.3 recessive 1:15,000 Alpha 1-antitrypsin deficiency: 14q32 co ...
Hematin and heme arginate is the treatment of choice during an acute attack. Heme is not a curative treatment, but can shorten attacks and reduce the intensity of an attack. Side-effects are rare but can be serious. [citation needed] Pain is extremely severe and almost always requires the use of opiates to reduce it to tolerable levels. Pain ...
Adenosine monophosphate deaminase deficiency type 1 or AMPD1, is a human metabolic disorder in which the body consistently lacks the enzyme AMP deaminase, [1] in sufficient quantities. This may result in exercise intolerance, muscle pain and muscle cramping. The disease was formerly known as myoadenylate deaminase deficiency (MADD).
There are no controlled treatment studies for 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency, making it difficult to determine the need for specific diet or carnitine supplements. The main therapy is avoiding fasting, with L-carnitine supplementation potentially detoxifying and preventing secondary insufficiency.